(RTTNews) - Purple Biotech Ltd. (PPBT, PPBT.TA), an Israeli clinical-stage biotechnology company, on Monday announced that it has appointed Shai Lankry as its Chief Financial Officer. Lankry has ...

Purple Biotech Ltd. has appointed Shai Lankry as its new Chief Financial Officer, bringing over 20 years of experience in financial leadership within the biotech and healthcare sectors.

REHOVOT, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug ...

About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

In this article, we will be taking a look at the 7 most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest ...

(Note: Jyong Biotech Ltd. increased its IPO’s size to 2.67 million shares – up from 2.33 million shares – and kept the price range at $7.50 to $8.50 – to raise $21.36 million, according to ...

BEIJING - Sinovac Biotech Ltd. (NASDAQ:SVA), a prominent biopharmaceutical company in China with a current market capitalization of $35.58 million, has announced the appointment of Sven H.